CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	May 31, 2021	May 31, 2020	May 31, 2021	May 31, 2020
Operating Activities:
Net income	$ 22,581	$ 12,633	$ 78,725	$ 58,053
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			48,350	44,867
Allowance for doubtful accounts			19	(18)
Loss on sale of property and equipment			568	251
Deferred income taxes			(2,748)	(4,079)
Equity in losses of unconsolidated affiliates	13	16	34	79
Stock-based compensation			13,221	9,976
Change in operating assets and liabilities:
Receivables, prepaid expenses and other current assets, non-current assets, accrued salaries and benefits, deferred membership income and other accruals			6,147	(157)
Merchandise inventories			(27,136)	62,511
Accounts payable			(37,213)	2,647
Net cash provided by operating activities			79,967	174,130
Investing Activities:
Additions to property and equipment			(73,350)	(89,713)
Purchases of short-term investments			(58,355)	(31,711)
Proceeds from settlements of short-term investments			37,605	8,891
Purchases of long-term investments			(1,479)	(1,489)
Proceeds from settlements of long-term investments			1,479
Proceeds from disposal of property and equipment			109	44
Net cash used in investing activities			(93,991)	(113,978)
Financing Activities:
Proceeds from long-term bank borrowings			3,000	57,820
Repayment of long-term bank borrowings			(13,135)	(7,542)
Proceeds from short-term bank borrowings				271,014
Repayment of short-term bank borrowings			(64,916)	(207,368)
Cash dividend payments			(11,108)	(10,811)
Purchase of treasury stock			(2,574)	(1,585)
Other financing activities			(223)	(20)
Net cash provided by (used in) financing activities			(88,956)	101,508
Effect of exchange rate changes on cash and cash equivalents and restricted cash			(2,351)	(1,872)
Net increase (decrease) in cash, cash equivalents			(105,331)	159,788
Cash, cash equivalents and restricted cash at beginning of period			303,771	106,236
Cash, cash equivalents and restricted cash at end of period	198,440	266,024	198,440	266,024
Supplemental disclosure of noncash investing activities:
Capital expenditures accrued, but not yet paid			8,763	7,975
Dividends declared but not yet paid	10,755	10,719	10,755	10,719
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents	190,687	261,788	190,687	261,788
Short-term restricted cash	781	240	781	240
Long-term restricted cash	6,972	3,996	6,972	3,996
Total cash, cash equivalents, and restricted cash shown in the consolidated statements of cash flows	$ 198,440	$ 266,024	$ 198,440	$ 266,024